Journal of International Oncology››2025,Vol. 52››Issue (10): 666-669.doi:10.3760/cma.j.cn371439-20250123-00114
• Original article •Previous ArticlesNext Articles
Received:2025-01-23Revised:2025-03-16Online:2025-10-08Published:2025-11-12
"
"
"
"
"
"
| [1] | 谢玲玲, 林仲秋. 《2024 NCCN子宫肿瘤临床实践指南(第1版)》解读[J].中国实用妇科与产科杂志,2023,39(11): 1122-1127. DOI:10.19538/j.fk2023110114. |
| [2] | Ikushima S, Ono R, Fukuda K, et al. Trousseau's syndrome: cancer-associated thrombosis[J].Jpn J Clin Oncol,2016,46(3): 204-208. DOI:10.1093/jjco/hyv165. pmid:26546690 |
| [3] | Ichinokawa H, Nagasaki Y, Koike Y, et al. Left pneumonectomy for primary lung cancer with trousseau's syndrome[J].BMJ Case Rep,2021,14(3): e240927. DOI:10.1136/bcr-2020-240927. |
| [4] | Ishikawa M, Nakayama K, Ishibashi T, et al. Case series of cerebral infarction with trousseau's syndrome associated with malignant gynecological tumors[J].Mol Clin Oncol,2016,5(1): 138-142. DOI:10.3892/mco.2016.888. pmid:27330786 |
| [5] | Taccone FS, Jeangette SM, Blecic SA. First-ever stroke as initial presentation of systemic cancer[J].J Stroke Cerebrovasc Dis,2008,17(4): 169-174. DOI:10.1016/j.jstrokecerebrovasdis.2008.01.007. pmid:18589335 |
| [6] | Navi BB, Iadecola C. Ischemic stroke in cancer patients: a review of an underappreciated pathology[J].Ann Neurol,2018,83(5): 873-883. DOI:10.1002/ana.25227. pmid:29633334 |
| [7] | Ling Y, Li Y, Zhang X, et al. Clinical features of trousseau's syndrome with multiple acute ischemic strokes[J].Neurol Sci,2022,43(4): 2405-2411. DOI:10.1007/s10072-021-05619-y. |
| [8] | Hirmerová J, Seidlerová J, Šubrt I, et al. Prevalence of cancer in patients with superficial vein thrombosis and its clinical importance[J].J Vasc Surg Venous Lymphat Disord,2022,10(1): 26-32. DOI:10.1016/j.jvsv.2021.05.006. |
| [9] | Tuar L, Usenik A, Turk B, et al. Mechanisms applied by protein inhibitors to inhibit cysteine proteases[J].Int J Mol Sci,2021,22(3): 997. DOI:10.3390/ijms22030997. |
| [10] | Jósa V, Brodszky V, Zaránd A, et al. The relationship between IL-6 and thrombocytosis accompanying gastrointestinal tumours[J].Prz Gastroenterol,2020,15(3): 215-219. DOI:10.5114/pg.2020.98538. pmid:33005266 |
| [11] | Li H, Yu Y, Gao L, et al. Tissue factor: a neglected role in cancer biology[J].J Thromb Thrombolysis,2022,54(1): 97-108. DOI:10.1007/s11239-022-02662-0. |
| [12] | Moik F, Ay C. Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies[J].Thromb Res,2022,213 Suppl 1: S58-S65. DOI:10.1016/j.thromres.2022.01.004. |
| [13] | Goff BA, Agnew K, Neradilek MB, et al. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass[J].Gynecol Oncol,2017,147(2): 291-295. DOI:10.1016/j.ygyno.2017.08.020. pmid:28860006 |
| [14] | Tsushima M, Metoki N, Hagii J, et al. D-dimer and C-reactive protein as potential biomarkers for diagnosis of trousseau's syndrome in patients with cerebral embolism[J].J Stroke Cerebrovasc Dis,2020,29(2): 104534. DOI:10.1016/j.jstrokecerebrovasdis.2019.104534. |
| [15] | Franco-Moreno A, Cabezón-Gutiérrez L, Palka-Kotlowsa M, et al. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update[J].J Thromb Thrombolysis,2019,47(3): 409-419. DOI:10.1007/s11239-018-1783-2. |
| [16] | Watanabe Y, Matsunuma K, Kaneda T. A case of successful anesthetic management in a patient with trousseau's syndrome who underwent surgery for malignant ovarian tumor[J].JA Clin Rep,2020,6(1): 32. DOI:10.1186/s40981-020-00339-2. |
| [17] | 王丽, 刘志华, 杨伟洪, 等. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J].国际肿瘤学杂志,2024,51(6): 382-384. DOI:10.3760/cma.j.cn371439-20240215-00066. |
| [18] | Neilson LE, Rogers LR, Sundararajan S. Evaluation and treatment of a patient with recurrent stroke in the setting of active malignancy[J].Stroke,2019,50(1): e9-e11. DOI:10.1161/STROKEAHA.118.022088. |
| [19] | Russo V, Falco L, Tessitore V, et al. Anti-inflammatory and anticancer effects of anticoagulant therapy in patients with malignancy[J].Life (Basel),2023,13(9): 1888. DOI:10.3390/life13091888. |
| [20] | Frere C, Farge D, Schrag D, et al. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials[J].J Hematol Oncol,2022,15(1): 69. DOI:10.1186/s13045-022-01289-1. |
| [21] | Van der Linden L, Vanassche T, Van Cutsem E, et al. Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis[J].Br J Clin Pharmacol,2023,89(8): 2369-2376. DOI:10.1111/bcp.15785. pmid:37170893 |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
